Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...

“Medicare Advantage and Part D plans often change from one year to the next, so people may see changes to their premiums, ...

The 2026 Part D plans became available to the public Oct. 1 at Medicare.gov, and there are serious changes, with Part D ...

Bayer and Kumquat launch a phase I study of KQB548, aiming to target various KRAS G12D-mutated tumors like pancreatic, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.

Late last month, Pfizer PFE announced a landmark deal with the Trump administration to cut drug prices and expand U.S.

Toni: Currently, I am on a stand-alone Part D plan with a Medicare Supplement plan G because of my serious health issues.

Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data. Lupin has received approval from the Food and Drug Administration for ...

Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...